8 cases of Hodgkin's disease, 1 case of chronic myeloid leukemia and 1 case of reticulosarcoma have been treated with sarcochlorine (DL-para-bis (β-chloroethyl) aminophenylalanine).
A marked cytostatic action of the compound, effectively influencing the general conditions, the febrile course and the zonal manifestations of the disease, was observed in all patients. Two negative aspects were demonstrated, i.e. a marked leukopenic influence of the cytostatic substance and a short duration of the clinical remissions.
Get full access to this article
View all access options for this article.
References
1.
BergelF., StockJ. A., J. Chem. Soc., 2409, 1954.
2.
Di PietroS., Min. Med., 11, 340, 1956.
3.
IzumiM., Pharm. Bull., 2, 275, 1954.
4.
IzumiM., Pharm. Bull., 3, 88, 1955.
5.
LarionovL. F., KhokhlovA. S., ShkodinskajaE. N., VasinaO. S., TroosheikinaV. I., e NovikovaM. A., Lancet, (6882, 169, 1955.
6.
YoskidaT., Annuals Meeting of the Japan Cancer Ass., Nagoya, 4 apr. 1954.
